With the passage of the 21st Century Cures Act in 2021, patients were granted access to their medical test results without delay—often before their physician can review them.
Congratulations to Thomas Annesley, PhD, DABCC, Active Professor Emeritus of Clinical Chemistry on his recognition with an Outstanding Lifetime Achievement Award in Clinical Chemistry and Laboratory Medicine from the Association for Diagnostics and Laboratory Medicine.
Congratulations on the investiture of Annette Kim, M.D., Ph.D., Professor of Pathology, and Director of the Division of Diagnostic Genetics and Genomics, with the Henry Clay Bryant Professorship in Pathology. This professorship was established to honor the legacy of Dr. Bryant, who received his medical degree and completed his pathology residency at the University of Michigan.
To understand why some cancers successfully circumvent the immune system to grow unchecked, researchers turned to pregnancy. “In pregnancy, the immune system does not reject the growing fetus, so we know there must be mechanisms active in the placenta. In cancer, it’s the same thing: the growing tumor is not rejected by the immune system. It means the cancer cells have developed strategies to suppress immune rejection, same as in pregnancy,” said Weiping Zou, M.D., Ph.D., professor of experimental pathology.
The University of Michigan Department of Pathology was honored to serve as co-host of this year’s Association of Pathology Informatics Summit, held at Eagle Crest Resort in Ypsilanti, Michigan, May 20-23, 2024. Director of Pathology Informatics Dr. Ulysses Balis served as this year’s conference director, along with Henry Ford Health System’s Dr. Mark Tuthill, who served as co-chair, with incredible support provided by U-M's Beth Gibson, conference manager and CME coordinator, and the U-M Pathology Informatics team who dedicated hundreds of hours toward the planning of this meeting. This year’s Summit enjoyed an exuberant turnout, with nearly 400 in attendance.